Mark Chin

PYXS

Mark Chin serves as an insider at Pyxis Oncology, Inc. (PYXS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$13.00M

Total Sells

1 trades

$5.32M

Net Position

Net Buyer

$7.68M

Companies Traded

PYXS, ELVN

Active Period

Jul 2021 – Apr 2022

3 total trades

Most Recent

Sell PYXS

Apr 25, 2022 · $5.32M

Mark Chin's Insider Trading at Pyxis Oncology, Inc. (PYXS)

Buys

1 · $5.00M

Sells

1 · $5.32M

Total Shares Bought

312,500

Total Shares Sold

1,745,761

PYXS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 25, 2022	Sell	1,745,761	$3.05	$5.32M	0
Oct 15, 2021	Buy	312,500	$16.00	$5.00M	1,745,761

Mark Chin's Insider Trading at Enliven Therapeutics, Inc. (ELVN)

Buys

1 · $8.00M

Sells

0 · $0.00

Total Shares Bought

1,333,333

Total Shares Sold

ELVN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 16, 2021	Buy	1,333,333	$6.00	$8.00M	2,344,072

Related Insiders

Helen Louise Collins

officer: CHIEF MEDICAL OFFICER

ELVNSell · Apr 21, 2026

HUMPHREY RACHEL

director

PYXSSell · Mar 25, 2026

Benjamin Hohl

officer: CHIEF FINANCIAL OFFICER

ELVNSell · Mar 10, 2026

Richard A. Heyman

Director

ELVNSell · Feb 19, 2026

Joseph P Lyssikatos

officer: CHIEF SCIENTIFIC OFFICER

ELVNSell · Feb 10, 2026

Anish Patel

officer: CHIEF OPERATING OFFICER

ELVNSell · Jan 13, 2026

Samuel Kintz

PRESIDENT AND CEO

ELVNSell · Nov 17, 2025

Explore More Insider Trading Data

PYXS Insider Trading Activity

View all insider trades at Pyxis Oncology, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity